Bayer
Monsanto board rejects Bayer’s $62 billion proposal
Monsanto's Board of Directors has unanimously viewed the Bayer proposal as incomplete and financially inadequate. The company, however, is open to continued and constructive conversations to assess whether a transaction in the best interest of Monsanto shareowners can... more »
Bayer makes Monsanto $62 billion offer
Bayer has made an all-cash $62 billion offer to acquire Monsanto. Bayer would acquire all of the issued and outstanding shares of common stock of Monsanto Company for $122 per share. Bayer's proposal was submitted... more »
Monsanto confirms acquisition proposal by Bayer
Bayer has confirmed company executives recently met with executives of Monsanto to privately discuss a negotiated acquisition of Monsanto. "The proposed combination would reinforce Bayer as a global innovation-driven Life Science company with leadership positions... more »
Bayer refuses EPA’s request to cancel use of flubendiamide
Crop Science, a division of Bayer, announced it has refused a request by the EPA to voluntarily cancel the uses of flubendiamide in the United States and instead will seek a review of the product’s... more »